AIRLINK 65.20 Decreased By ▼ -0.70 (-1.06%)
BOP 5.57 Decreased By ▼ -0.12 (-2.11%)
CNERGY 4.56 Decreased By ▼ -0.09 (-1.94%)
DFML 24.52 Increased By ▲ 1.67 (7.31%)
DGKC 69.96 Decreased By ▼ -0.74 (-1.05%)
FCCL 20.30 Decreased By ▼ -0.05 (-0.25%)
FFBL 29.11 No Change ▼ 0.00 (0%)
FFL 9.83 Decreased By ▼ -0.10 (-1.01%)
GGL 10.01 Decreased By ▼ -0.07 (-0.69%)
HBL 114.25 Decreased By ▼ -1.00 (-0.87%)
HUBC 129.10 Decreased By ▼ -0.40 (-0.31%)
HUMNL 6.71 Increased By ▲ 0.01 (0.15%)
KEL 4.44 Increased By ▲ 0.06 (1.37%)
KOSM 4.89 Decreased By ▼ -0.13 (-2.59%)
MLCF 37.00 Increased By ▲ 0.04 (0.11%)
OGDC 132.30 Increased By ▲ 1.10 (0.84%)
PAEL 22.54 Increased By ▲ 0.06 (0.27%)
PIAA 25.89 Decreased By ▼ -0.41 (-1.56%)
PIBTL 6.60 Increased By ▲ 0.07 (1.07%)
PPL 112.85 Increased By ▲ 0.73 (0.65%)
PRL 29.41 Increased By ▲ 1.02 (3.59%)
PTC 15.24 Decreased By ▼ -0.87 (-5.4%)
SEARL 57.03 Decreased By ▼ -1.26 (-2.16%)
SNGP 66.45 Increased By ▲ 0.76 (1.16%)
SSGC 10.98 Decreased By ▼ -0.04 (-0.36%)
TELE 8.80 Decreased By ▼ -0.14 (-1.57%)
TPLP 11.70 Increased By ▲ 0.17 (1.47%)
TRG 68.62 Decreased By ▼ -0.62 (-0.9%)
UNITY 23.40 Decreased By ▼ -0.55 (-2.3%)
WTL 1.38 Increased By ▲ 0.03 (2.22%)
BR100 7,295 Decreased By -9.1 (-0.12%)
BR30 23,854 Decreased By -96 (-0.4%)
KSE100 70,290 Decreased By -43.2 (-0.06%)
KSE30 23,171 Increased By 50.4 (0.22%)

imageTOKYO: Some of Japan's top scientists have been unable to reproduce results of what was once billed as a ground-breaking stem cell study, but which spiralled into a scandal that included a respected researcher's suicide, reports said Thursday.

The government-backed Riken Institute will announce Friday that so-called "STAP" cells cannot be reproduced, writing the embarrassing final chapter of a study published in the journal Nature but later withdrawn, according to national broadcaster NHK.

"Cells with pluripotency could not be created under the method spelled out in the study," NHK said, citing unnamed sources.

Riken in January trumpeted how Haruko Obokata, now 31, had devised a simple method to re-programme adult cells to work like stem cells -- the precursors that are capable of developing into any other cell in the human body.

The study was top news in Japan, where the photogenic Obokata, a Harvard-trained scientist, became a phenomenon.

But media attention soon grew into scepticism as doubts emerged about Obokata's papers on Stimulus-Triggered Acquisition of Pluripotency (STAP).

Mistakes were discovered in some data published in two papers, photograph captions were found to be misleading, and the work itself could not be repeated by other scientists.

Obokata, who asserted that she created STAP cells some 200 times, since July has been trying in tandem with independent teams to reproduce her own results.

She claimed there was a secret knack for creating STAP cells, but has refused to publicise it, asserting it is a subject of her future papers.

Leading science journal Nature withdrew the flawed study after Obokata agreed in June to retract the papers.

As the scandal deepened, Obokata's mentor and co-author, stem cell scientist Yoshiki Sasai, hanged himself, further shaking Japan's scientific establishment.

Riken has pledged to restructure its Center for Developmental Biology where the scandal took place.

Copyright AFP (Agence France-Presse), 2014

Comments

Comments are closed.